Status: Recruiting
A Phase Ib/II Exploratory Clinical Trial of Memory-Enhanced 7×19-THEMIS CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma
This study is aimed to explored the safety and efficacy of 7×19-THEMIS CAR-T cell therapy for large B-cell lymphoma and to conduct an exploratory comparison of the 3-month objective response rate (ORR) and complete remission rate (CR rate) between the experimental cohort and the historical control cohort (NCT04833504).
Participants needed: 70
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Second Affiliated Hospital, Zhejiang University, School of MedicineUpdated: Aug 26, 2026Locations: 1
Eligibility criteria
Voluntarily participate in this study and sign the informed consent form. [+11]
History of other malignant tumors (excluding cured basal cell carcinoma, cervica... [+8]